The multicomponent medication lymphomyosot improves the outcome of experimental lymphedema
多组分药物淋巴肌瘤可改善实验性淋巴水肿的预后。
期刊:Lymphatic Research and Biology
影响因子:1.9
doi:10.1089/lrb.2012.0024
Keim, Alex P; Slis, Justin R; Mendez, Uziel; Stroup, Emily M; Burmeister, Yvonne; Tsolaki, Natalie; Gailing, Oliver; Goldman, Jeremy